Axel Polymers Limited has formally communicated that there has been no deviation or variation in the utilization of funds raised through its preferential issue. The statement, pertaining to the quarter ended September 30, 2026, confirms that the net proceeds from the equity shares allotted on December 13, 2025, have been utilized as originally planned. This disclosure aims to provide transparency and assurance to stakeholders regarding the financial management of the company.
Axel Polymers Confirms No Deviation in Preferential Issue Fund Utilization
Axel Polymers Limited has submitted a statement to the stock exchanges confirming the utilization of funds raised via a preferential issue. The company explicitly stated that for the quarter ending September 30, 2026, there have been no deviations or variations in how the proceeds from the preferential issue of equity shares, allotted on December 13, 2025, have been utilized.
Statement of No Variance
In accordance with regulatory requirements, Axel Polymers provided a detailed statement outlining the utilization of funds. The company has confirmed that the net proceeds from the preferential issue have been employed precisely as per the original disclosure. This confirmation indicates effective financial stewardship and adherence to the approved objectives for the fund utilization.
Financial Transparency
The statement is a routine submission aimed at ensuring transparency in the company’s financial operations and compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management and auditors have verified that the funds raised were used in alignment with the planned allocation, with no changes noted against the originally disclosed objects or amounts.
Source: BSE
